Dan Li

机构：Shenyang Pharmaceutical University, Shanghai Jiao Tong University, Chinese Center For Disease Control and Prevention, Zhengzhou University, Affiliated Hospital of Southwest Medical University, Central Hospital Affiliated to Shenyang Medical College, National Center for AIDS/STD Control and Prevention,China CDC, Henan Provincial People's Hospital, Gilead Sciences (United States), National Institute for Communicable Disease Control and Prevention, The Sixth People's Hospital of Zhengzhou, Shanghai Children's Hospital · ORCID：0000-0003-1596-8033

发表论文 67 篇 · 总被引 958 次 · h-index 18

代表论文

• Changes in HIV-1 Subtypes/Sub-Subtypes, and Transmitted Drug Resistance Among ART-Naïve HIV-Infected Individuals — China, 2004–2022 (2023 · China CDC Weekly · 被引 61)
• Pretreatment HIV Drug Resistance and the Molecular Transmission Network Among HIV-Positive Individuals in China in 2022: Multicenter Observational Study (2023 · JMIR Public Health and Surveillance · 被引 29)
• Relating biodiversity with health disparities of human population: An ecological study across the United States (2023 · One Health · 被引 20)
• Specialized cis -Acting RNA Elements Balance Genome Cyclization to Ensure Efficient Replication of Yellow Fever Virus (2023 · Journal of Virology · 被引 8)
• Isolation and Characterization of E8 Monoclonal Antibodies from Donors Vaccinated with Recombinant Vaccinia Vaccine with Efficient Neutralization of Authentic Monkeypox Virus (2025 · Vaccines · 被引 7)
• Broad-spectrum anti-HIV activity and high drug resistance barrier of lipopeptide HIV fusion inhibitor LP-19 (2023 · Frontiers in Immunology · 被引 7)